| 肝复乐胶囊预防原发性肝癌经导管动脉化疗栓塞后肝损伤 |
| |
| 引用本文： | 吴孝雄,陈挺松,孙保木,时良慧,吴胜兵,罗明. 肝复乐胶囊预防原发性肝癌经导管动脉化疗栓塞后肝损伤[J]. 中成药, 2014, 0(12): 2475-2478 |
| |
| 作者姓名： | 吴孝雄 陈挺松 孙保木 时良慧 吴胜兵 罗明 |
| |
| 作者单位： | 第二军医大学东方肝胆外科医院中西医结合科 |
| |
| 摘 要： | ![]()
目的观察肝复乐胶囊(党参、鳖甲、重楼、白术、黄芪等组成)预防原发性肝癌患者经导管动脉化疗栓塞肝损伤的临床效果。方法观察组44例入院时已口服肝复乐胶囊1个月,对照组44例未服用抗肿瘤中药。两组患者均入院行导管动脉化疗栓塞,比较治疗后肝损伤情况。结果两组患者经导管动脉化疗栓塞后观察组总胆红素(25.08±10.59μmol/L)、丙氨酸氨基转移酶(107.81±171.95 U/L)、天门冬氨酸转移酶(149.21±153.31 U/L),对照组分别为(35.30±20.18μmol/L)、(263.44±372.78 U/L)、(279.78±288.07 U/L),两组比较差异均有统计学意义(P<0.05),但白蛋白比较差异无统计学意义(P>0.05)。结论导管动脉化疗栓塞前口服肝复乐胶囊能减轻导管动脉化疗栓塞后肝损伤。
|
| 关 键 词： | 原发性肝癌 导管动脉化疗栓塞 肝损伤 肝复乐胶囊 |
Ganfule Capsules prevent the hepatic injury in patients with primary liver carcinoma receiving transcatheter arterial chemoembolization |
| |
| WU Xiao-xiong;CHEN Ting-song;SUN Bao-mu;SHI Liang-hui;WU Sheng-bing;LUO Ming. Ganfule Capsules prevent the hepatic injury in patients with primary liver carcinoma receiving transcatheter arterial chemoembolization[J]. Chinese Traditional Patent Medicine, 2014, 0(12): 2475-2478 |
| |
| Authors: | WU Xiao-xiong CHEN Ting-song SUN Bao-mu SHI Liang-hui WU Sheng-bing LUO Ming |
| |
| Affiliation: | WU Xiao-xiong;CHEN Ting-song;SUN Bao-mu;SHI Liang-hui;WU Sheng-bing;LUO Ming;Traditional Chinese and Western Medicine Integrated Department,Eastern Hepatobiliary Surgery Hospital,The Second Military Medical University; |
| |
| Abstract: | ![]()
|
| |
| Keywords: | |
| 本文献已被 CNKI 等数据库收录！ |
|
